This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Patients with post polycythemia vera myelofibrosis might experience increased thrombotic risk in comparison to primary and post essential thrombocythemia myelofibrosis. (August 2022)
Record Type:
Journal Article
Title:
Patients with post polycythemia vera myelofibrosis might experience increased thrombotic risk in comparison to primary and post essential thrombocythemia myelofibrosis. (August 2022)
Main Title:
Patients with post polycythemia vera myelofibrosis might experience increased thrombotic risk in comparison to primary and post essential thrombocythemia myelofibrosis
Highlights: Post-PV SMF patients experience highest risk of arterial thrombotic events in comparison to PMF and post-ET SMF. High thrombotic risk persists in the multivariate model adjusted for relevant predictors. Post-ET SMF patients experience most favorable survival in comparison to other subsets.